Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A

BMC Microbiology

Volumn 11, Issue , 2011, Pages

  Florio, Ada Rita ^a   Ferrari, Selene ^b   De Carolis, Elena ^a   Torelli, Riccardo ^a   Fadda, Giovanni ^a   Sanguinetti, Maurizio ^a   Sanglard, Dominique ^b   Posteraro, Brunella ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ALPHA GLUCOSIDASE; ALPHA MANNOSIDASE; AMINO ACID TRANSPORTER; ARGINASE; CARNITINE ACETYLTRANSFERASE; CATALASE; CELLULASE; ERGOSTEROL; FLUCONAZOLE; GLUTAMATE DEHYDROGENASE; GLUTAMATE SYNTHASE (NADH); GLYCOPROTEIN P; HEAT SHOCK PROTEIN 70; HOMOSERINE ACETYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; INOSITOL OXYGENASE; ISOCITRATE DEHYDROGENASE; LANOSTEROL SYNTHASE; LYSOPHOSPHOLIPASE; OXIDOREDUCTASE; PHOSPHATIDYLSERINE DECARBOXYLASE; PROLINE DEHYDROGENASE; SQUALENE MONOOXYGENASE; STEROL 14ALPHA DEMETHYLASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSALDOLASE; TRANSKETOLASE; ANTIFUNGAL AGENT;

ARTICLE; BIOSYNTHESIS; CELL STRESS; CELL STRUCTURE; CELL TRANSPORT; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; FUNGAL STRAIN; FUNGAL VIRULENCE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; NONHUMAN; SEROTYPE; UPREGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

CRYPTOCOCCUS NEOFORMANS VAR. GRUBII;

ANTIFUNGAL AGENTS; CRYPTOCOCCUS NEOFORMANS; FLUCONAZOLE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; STRESS, PHYSIOLOGICAL;

EID: 79955755449     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-11-97     Document Type: Article

References (53)

1. Cryptococcosis. JR Perfect A Casadevall, Infect Dis Clin North Am 2002 16 837 874 10.1016/S0891-5520(02)00036-3 12512184 (Pubitemid 35477516)
2. Cryptococcal meningitis. T Bicanic TS Harrison, Br Med Bull 2005 72 99 118 10.1093/bmb/ldh043 15838017 (Pubitemid 40712661)
3. How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans. TL Doering, Annu Rev Microbiol 2009 63 223 247 10.1146/annurev.micro.62.081307.162753 19575556
4. Fungal infections in solid organ transplantation. FP Silveira S Husain, Med Mycol 2007 45 305 320 10.1080/13693780701200372 17510855 (Pubitemid 46839801)
5. Prevalence of HIV-associated cryptococcal meningitis and utility of microbiological determinants for its diagnosis in a tertiary care center. R Thakur S Sarma S Kushwaha, Indian J Pathol Microbiol 2008 51 212 214 10.4103/0377-4929.41689 18603684 (Pubitemid 351961360)
6. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. BJ Park KA Wannemuehler BJ Marston N Govender PG Pappas TM Chiller, AIDS 2009 23 525 530 10.1097/QAD.0b013e328322ffac 19182676
7. Fluconazole and itraconazole susceptibilities of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India; a need for care. K Datta N Jain S Sethi A Rattan A Casadevall U Banerjee, J Antimicrob Chemother 2003 52 683 686 10.1093/jac/dkg399 12951350 (Pubitemid 37258433)
8. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002. B Sar D Monchy M Vann C Keo JL Sarthou Y Buisson, J Antimicrob Chemother 2004 54 563 565 10.1093/jac/dkh361 15254027 (Pubitemid 39177489)
9. Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya. CC Bii K Makimura S Abe H Taguchi OM Mugasia G Revathi NC Wamae S Kamiya, Mycoses 2007 50 25 30 10.1111/j.1439-0507.2006.01293. x 17302744 (Pubitemid 46046416)
10. Drug resistance in Cryptococcus neoformans. JR Perfect GM Cox, Drug Resist Updat 1999 2 259 269 10.1054/drup.1999.0090 11504497 (Pubitemid 29526248)
11. Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence. E Sionov YC Chang HM Garraffo KJ Kwon-Chung, Antimicrob Agents Chemother 2009 53 2804 2815 10.1128/AAC.00295-09 19414582
12. Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans. P Mondon R Petter G Amalfitano R Luzzati E Concia I Polacheck KJ Kwon-Chung, Antimicrob Agents Chemother 1999 43 1856 1861 10428902 (Pubitemid 29395175)
13. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes. E Sionov H Lee YC Chang KJ Kwon-Chung, PLoS Pathog 2010 6 1000848 10.1371/journal.ppat.1000848 20368972
14. Molecular basis of resistance to azole antifungals. A Lupetti R Danesi M Campa M Del Tacca S Kelly, Trends Mol Med 2002 8 76 81 10.1016/S1471-4914(02) 02280-3 11815273 (Pubitemid 34094443)
15. Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole. B Posteraro M Sanguinetti D Sanglard M La Sorda S Boccia L Romano G Morace G Fadda, Mol Microbiol 2003 47 357 371 10.1046/j.1365-2958.2003.03281.x 12519188 (Pubitemid 36121027)
16. The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. BJ Loftus E Fung P Roncaglia D Rowley P Amedeo D Bruno J Vamathevan M Miranda IJ Anderson JA Fraser JE Allen IE Bosdet MR Brent R Chiu TL Doering MJ Donlin CA D'Souza DS Fox V Grinberg J Fu M Fukushima BJ Haas JC Huang G Janbon SJ Jones HL Koo MI Krzywinski JK Kwon-Chung KB Lengeler R Maiti MA Marra RE Marra CA Mathewson TG Mitchell M Pertea FR Riggs SL Salzberg JE Schein A Shvartsbeyn H Shin M Shumway CA Specht BB Suh A Tenney TR Utterback BL Wickes JR Wortman NH Wye JW Kronstad JK Lodge J Heitman RW Davis CM Fraser RW Hyman, Science 2005 307 1321 1324 10.1126/science.1103773 15653466 (Pubitemid 40299983)
17. Cryptococcus neoformans, a fungus under stress. SM Brown LT Campbell JK Lodge, Curr Opin Microbiol 2007 10 320 325 10.1016/j.mib.2007.05.014 17707685 (Pubitemid 47404946)
18. A link between virulence and homeostatic responses to hypoxia during infection by the human fungal pathogen Cryptococcus neoformans. CD Chun OW Liu HD Madhani, PLoS Pathog 2007 3 22 10.1371/journal.ppat.0030022 17319742
19. Efflux in fungi: la pièce de résistance. JJ Coleman E Mylonakis, PLoS Pathog 2009 5 1000486 10.1371/journal.ppat.1000486 19557154
20. Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in Cryptococcus neoformans. YC Chang CM Bien H Lee PJ Espenshade KJ Kwon-Chung, Mol Microbiol 2007 64 614 629 10.1111/j.1365-2958.2007.05676.x 17462012 (Pubitemid 46653205)
21. New insights on the pathogenesis of invasive Cryptococcus neoformans infection. HC Eisenman A Casadevall EE McClelland, Curr Infect Dis Rep 2007 9 457 464 10.1007/s11908-007-0070-8 17999881 (Pubitemid 350081425)
22. +-ATPase, an antifungal target in Cryptococcus neoformans. P Soteropoulos T Vaz R Santangelo P Paderu DY Huang MJ Tamás DS Perlin, Antimicrob Agents Chemother 2000 44 2349 2355 10.1128/AAC.44.9.2349-2355.2000 10952578 (Pubitemid 30650878)
23. Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans. M Sanguinetti B Posteraro M La Sorda R Torelli B Fiori R Santangelo G Delogu G Fadda, Infect Immun 2006 74 1352 1359 10.1128/IAI.74.2.1352-1359.2006 16428784 (Pubitemid 43185574)
24. 2sensing pathway via differential expression of carbonic anhydrase in Cryptococcus neoformans. MS Kim YJ Ko S Maeng A Floyd J Heitman YS Bahn, Genetics 2010 185 1207 1219 10.1534/genetics.110.118315 20516494
25. Gene Expression Omnibus (GEO): Microarray data storage, submission, retrieval, and analysis. ER Barrett, Methods Enzymol 2006 411 352 369 16939800
26. Fluconazole at subinhibitory concentrations induces the oxidative- and nitrosative-responsive genes TRR1, GRE2 and YHB1, and enhances the resistance of Candida albicans to phagocytes. DM Arana C Nombela J Pla, J Antimicrob Chemother 2010 65 54 62 10.1093/jac/dkp407 19897505
27. Cell wall integrity is dependent on the PKC1 signal transduction pathway in Cryptococcus neoformans. KJ Gerik MJ Donlin CE Soto AM Banks IR Banks MA Maligie CP Selitrennikoff JK Lodge, Mol Microbiol 2005 58 393 408 10.1111/j.1365-2958.2005.04843.x 16194228 (Pubitemid 41476157)
28. Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol. GF Bammert JM Fostel, Antimicrob Agents Chemother 2000 44 1255 1265 10.1128/AAC.44.5.1255-1265.2000 10770760 (Pubitemid 30228303)
29. Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. MD De Backer T Ilyina XJ Ma S Vandoninck WH Luyten H Vanden Bossche, Antimicrob Agents Chemother 2001 45 1660 1670 10.1128/AAC.45.6.1660-1670.2001 11353609 (Pubitemid 32466332)
30. Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans. S Gamarra EM Rocha YQ Zhang S Park R Rao DS Perlin, Antimicrob Agents Chemother 2010 54 1753 1761 10.1128/AAC.01728-09 20194694
31. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. M Karababa AT Coste B Rognon J Bille D Sanglard, Antimicrob Agents Chemother 2004 48 3064 3079 10.1128/AAC.48.8.3064- 3079.2004 15273122 (Pubitemid 38989176)
32. Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action. H Vanden Bossche, Curr Top Med Mycol 1985 1 313 351 3916772
33. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. KW Henry JT Nickels TD Edlind, Antimicrob Agents Chemother 2000 44 2693 2700 10.1128/AAC.44.10.2693-2700.2000 10991846
34. Protein sensors for membrane sterols. JL Goldstein RA Debose-Boyd MS Brown, Cell 2006 124 35 46 10.1016/j.cell.2005.12.022 16413480
35. Cryptococcus neoformans Site-2 protease is required for virulence and survival in the presence of azole drugs. CM Bien YC Chang WD Nes KJ Kwon-Chung PJ Espenshade, Mol Microbiol 2009 74 672 690 10.1111/j.1365-2958.2009.06895.x 19818023
36. Sterol regulatory element binding proteins in fungi: hypoxic transcription factors linked to pathogenesis. CM Bien PJ Espenshade, Eukaryot Cell 2010 9 352 359 10.1128/EC.00358-09 20118213
37. Conservation of the sterol regulatory element-binding protein pathway and its pathobiological importance in Cryptococcus neoformans. YC Chang SS Ingavale C Bien P Espenshade KJ Kwon-Chung, Eukaryot Cell 2009 8 1770 1779 10.1128/EC.00207-09 19749173
38. Lipid signaling in pathogenic fungi. R Rhome M Del Poeta, Annu Rev Microbiol 2009 63 119 131 10.1146/annurev.micro.091208.073431 19450140
39. Cell wall-linked cryptococcal phospholipase B1 is a source of secreted enzyme and a determinant of cell wall integrity. AR Siafakas TC Sorrell LC Wright C Wilson M Larsen R Boadle PR Williamson JT Djordjevic, J Biol Chem 2007 282 37508 37514 10.1074/jbc.M707913200 17947228
40. Fungal echinocandin resistance. LA Walker NA Gow CA Munro, Fungal Genet Biol 2010 47 117 126 10.1016/j.fgb.2009.09.003 19770064
41. Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. LG Baker CA Specht MJ Donlin JK Lodge, Eukaryot Cell 2007 6 855 867 10.1128/EC.00399-06 17400891 (Pubitemid 46835048)
42. Involvement of yeast YOL151W/GRE2 in ergosterol metabolism. J Warringer A Blomberg, Yeast 2006 23 389 398 10.1002/yea.1363 16598690
43. Enzymes that counteract nitrosative stress promote fungal virulence. M de Jesús-Berríos L Liu JC Nussbaum GM Cox JS Stamler J Heitman, Curr Biol 2003 13 1963 1968 10.1016/j.cub.2003.10.029 14614821 (Pubitemid 37425205)
44. Identification of Cryptococcus neoformans temperature-regulated genes with a genomic-DNA microarray. PR Kraus MJ Boily SS Giles JE Stajich A Allen GM Cox FS Dietrich JR Perfect J Heitman, Eukaryot Cell 2004 3 1249 1260 10.1128/EC.3.5.1249-1260.2004 15470254 (Pubitemid 39385233)
45. The Hsp70 member, Ssa1, acts as a DNA-binding transcriptional co-activator of laccase in Cryptococcus neoformans. S Zhang M Hacham J Panepinto G Hu S Shin X Zhu PR Williamson, Mol Microbiol 2006 62 1090 1101 10.1111/j.1365-2958.2006.05422.x 17040492 (Pubitemid 44655320)
46. Decreased virulence in stable, acapsular mutants of Cryptococcus neoformans. RA Fromtling HJ Shadomy ES Jacobson, Mycopathologia 1982 79 23 29 10.1007/BF00636177 6750405 (Pubitemid 13227139)
47. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. YC Chang KJ Kwon-Chung, Mol Cell Biol 1994 14 4912 4919 8007987 (Pubitemid 24196840)
48. Cas3p belongs to a seven-member family of capsule structure designer proteins. F Moyrand YC Chang U Himmelreich KJ Kwon-Chung G Janbon, Eukaryot Cell 2004 3 1513 1524 10.1128/EC.3.6.1513-1524.2004 15590825 (Pubitemid 40025109)
49. Remodeling of global transcription patterns of Cryptococcus neoformans genes mediated by the stress-activated HOG signaling pathways. YJ Ko YM Yu GB Kim GW Lee PJ Maeng S Kim A Floyd J Heitman YS Bahn, Eukaryot Cell 2009 8 1197 1217 10.1128/EC.00120-09 19542307
50. Efflux-mediated antifungal drug resistance. RD Cannon E Lamping AR Holmes K Niimi PV Baret MV Keniya K Tanabe M Niimi A Goffeau BC Monk, Clin Microbiol Rev 2009 22 291 321 10.1128/CMR.00051-08 19366916
51. Combined phylogeny and neighborhood analysis of the evolution of the ABC transporters conferring multiple drug resistance in hemiascomycete yeasts. ML Seret JF Diffels A Goffeau PV Baret, BMC Genomics 2009 10 459 10.1186/1471-2164-10-459 19796374
52. Identification of a novel system for boron transport: Atr1 is a main boron exporter in yeast. A Kaya HC Karakaya DE Fomenko VN Gladyshev A Koc, Mol Cell Biol 2009 29 3665 3674 10.1128/MCB.01646-08 19414602
53. Drug:H+ antiporters in chemical stress response in yeast. I Sá-Correia SC dos Santos MC Teixeira TR Cabrito NP Mira, Trends Microbiol 2009 17 22 31 10.1016/j.tim.2008.09.007 19062291